GMAB

Q: What is the price of Genmab (GMAB) today?

The price of Genmab (GMAB) today is $ 30.82, with return of 48.24% compared to the last year. The price of Genmab (GMAB) started the year trading around $ 20.87 and today it is at $ 30.82. Follow the real-time price chart, the historical price of Genmab (GMAB) and international markets.

Q: When does Genmab (GMAB) pay dividends?

Genmab (GMAB) did not distribute dividends in the last year.

Q: Is Genmab (GMAB) worth it?

Currently, Genmab (GMAB) is priced at $ 30.82, with a P/E of 14.37%, representando um desvio de 3,026% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 48.24 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 48.24%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Genmab (GMAB) stock?

Investing in stocks of Genmab (GMAB) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Genmab (GMAB) yield today?

The yield of Genmab (GMAB) was 3.11% in the last month, 48.24% in the last year and -16.99% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Genmab (GMAB) today, the total investment would be $ 3,082.00, based on the current price of $ 30.82.If past performance were to repeat, the return on your investment would be:In 1 year: $ 4,568.76In 5 years: $ 2,558.37In 10 years: $ 7,364.44It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Genmab A/S

Price

$ 30.82

return (12m)

48.24%

p/e

14.37

p/bv

3.26

DIVIDEND YIELD

0.00%

price GMAB

BVMF

GMAB

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, you would now have

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of GMAB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.11%

3 months

24.37%

1 year

48.24%

2 years

0.39%

5 years

-16.99%

10 years

138.95%

Fundamentals GMAB

review the fundamentals of Genmab shares

P/E

14.37

Sector: 8.84 Industry: 47.93

P/SALES RATIO (PSR)

6.35

Sector: 0.98 Industry: 3.80

P/BV

3.26

Sector: 1.62 Industry: 16.01

DIVIDEND YIELD (DY)

0.00%

Sector: 0.43% Industry: 1.31%

ROA

18.59%

Sector: 1.05% Industry: 10.51%

ROE

22.69%

Sector: 4.70% Industry: 33.40%

ROIC

52.26%

Sector: -3.74% Industry: 15.30%

NET MARGIN

44.17%

Sector: 1.79% Industry: 14.65%

GROSS MARGIN

94.30%

Sector: 38.43% Industry: 50.05%

OPERATING MARGIN

39.05%

Sector: 5.57% Industry: 14.59%

P/EBITDA

12.35

Sector: 5.05 Industry: 26.82

P/EBIT

12.79

Sector: 5.92 Industry: 33.41

P/ASSET

2.67

Sector: 0.76 Industry: 3.24

BVPS

9.34

Sector: 10.17 Industry: 121.92

EPS

2.12

Sector: 0.79 Industry: 40.73

EQUITY RATIO

0.82

Sector: 0.31 Industry: 0.59

CAGR REVENUE 5 YEARS

13.59%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

12.36%

Sector: - Industry: -

FAIR VALUE OF Genmab ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 30.82

Fair Value

$ 0.00

Upside Return potential.

-31.51%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GMAB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
AMZN	30.80	6.37	20.69%	0.00%	$ 2.36 T	11.06%
MELI	47.93	16.01	33.40%	0.00%	$ 99.54 B	7.93%
DIS	14.90	1.61	10.82%	0.97%	$ 184.81 B	13.14%
VZ	8.79	1.64	18.65%	6.60%	$ 174.32 B	14.43%
MCD	26.05	-101.36	-389.04%	2.30%	$ 219.24 B	32.04%
WMT	36.58	8.17	22.35%	0.87%	$ 837.95 B	3.26%
COST	49.29	13.69	27.77%	0.56%	$ 399.16 B	2.94%
BABA	17.43	2.33	13.37%	1.31%	$ 354.95 B	14.65%
V	27.68	14.64	52.91%	0.72%	$ 555.15 B	50.15%
T	8.34	1.44	17.28%	4.28%	$ 185.56 B	17.87%
NFLX	4.24	1.70	40.19%	0.00%	$ 44.23 B	24.05%
SBUX	51.90	-11.91	-22.95%	2.88%	$ 96.35 B	4.99%
HD	25.74	35.31	137.17%	2.41%	$ 376.55 B	8.86%
TGT	10.44	2.53	24.28%	5.20%	$ 39.28 B	3.58%
CMCSA	4.45	1.03	23.16%	4.75%	$ 100.62 B	18.33%
LBRDP	1.40	0.36	25.89%	7.70%	$ 3.27 B	100.00%
CMG	27.48	13.11	47.69%	0.00%	$ 42.23 B	13.04%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

GMAB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Genmab

Genmab A/S

Average user rating I10

4.0 (3 people)

United States

27 years

Founded: 1998

2019

Time since IPO - 6 years

781

Employees

The Company Genmab A/S (United States), is listed on Nasdaq with a market cap of $ 18.76 Billions, having an equity of $ 5.75 Billions.

With a total of 781 employees, the company is listed in the sector of Services and categorized in industry of Commercial Services.

In the last 12 months the Company had a revenue of $ 2.96 Billions, which generated a profit in the amount of $ 1.31 Billion.

As for its main indicators, the Company has a P/E ratio of 14.37, a P/BV ratio of 3.26 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker GMAB.

Market cap

$ 18.76 Billions

Equity

$ 5.75 Billions

US$ 5,751,000,000.00

Assets

$ 7.02 Billions

US$ 7,021,000,000.00

Total Shares Outstanding

616.00 Millions

616,000,000

Average Daily Trading Volume

$ 2.27 Millions

US$ 2,274,037.12

Sector

Services

Industry

Commercial Services

GMAB

GMAB revenue and profits

Financial Results GMAB

DRAG THE FRAME TO SEE MORE DATA

GMAB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

WSG - Wanda Sports Group

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-7.74%

P/BV

0.00

AMZN - Amazon

$ 226.28 9,98% (12M)

P/E

30.80

0.00%

ROE

20.69%

P/BV

6.37

WMT - Walmart

$ 104.06 17,66% (12M)

P/E

36.58

0.87%

ROE

22.35%

P/BV

8.17

COST - Costco Wholesale

$ 886.12 --7,30% (12M)

P/E

49.29

0.56%

ROE

27.77%

P/BV

13.69

JD - JD.com

$ 29.06 --13,74% (12M)

P/E

8.74

2.97%

ROE

12.98%

P/BV

1.13

HD - Home Depot

$ 336.58 --19,62% (12M)

P/E

25.74

2.41%

ROE

137.17%

P/BV

35.31

WBA - Walgreens Boots Alliance

$ - -0,00% (12M)

P/E

-1.76

4.17%

ROE

-80.35%

P/BV

1.42

BABA - Alibaba

$ 160.73 87,81% (12M)

P/E

17.43

1.31%

ROE

13.37%

P/BV

2.33

WSG - Wanda Sports Group

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-7.74%

P/VP

0.00

AMZN - Amazon

$ 226.28 9,98% (12 M)

P/L

30.80

0.00%

ROE

20.69%

P/VP

6.37

WMT - Walmart

$ 104.06 17,66% (12 M)

P/L

36.58

0.87%

ROE

22.35%

P/VP

8.17

COST - Costco Wholesale

$ 886.12 --7,30% (12 M)

P/L

49.29

0.56%

ROE

27.77%

P/VP

13.69

JD - JD.com

$ 29.06 --13,74% (12 M)

P/L

8.74

2.97%

ROE

12.98%

P/VP

1.13

HD - Home Depot

$ 336.58 --19,62% (12 M)

P/L

25.74

2.41%

ROE

137.17%

P/VP

35.31

WBA - Walgreens Boots Alliance

$ - -0,00% (12 M)

P/L

-1.76

4.17%

ROE

-80.35%

P/VP

1.42

BABA - Alibaba

$ 160.73 87,81% (12 M)

P/L

17.43

1.31%

ROE

13.37%

P/VP

2.33

Frequently Asked Questions

What is the price of Genmab (GMAB) today?

The price of Genmab (GMAB) today is $ 30.82, with return of 48.24% compared to the last year. The price of Genmab (GMAB) started the year trading around $ 20.87 and today it is at $ 30.82. Follow the real-time price chart, the historical price of Genmab (GMAB) and international markets.

When does Genmab (GMAB) pay dividends?

Genmab (GMAB) did not distribute dividends in the last year.

Is Genmab (GMAB) worth it?

Currently, Genmab (GMAB) is priced at $ 30.82, with a P/E of 14.37%, representando um desvio de 3,026% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 48.24 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 48.24%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Genmab (GMAB) stock?

Investing in stocks of Genmab (GMAB) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Genmab (GMAB) yield today?

The yield of Genmab (GMAB) was 3.11% in the last month, 48.24% in the last year and -16.99% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Genmab (GMAB) today, the total investment would be $ 3,082.00, based on the current price of $ 30.82.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 4,568.76
In 5 years: $ 2,558.37
In 10 years: $ 7,364.44

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GMAB

Genmab A/S

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of GMAB

review the fundamentals of Genmab shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Genmab

Genmab A/S

United States

27 years

2019

781

PROFIT X PRICE GMAB

Financial Results GMAB

GMAB cash flow

asset growth - GMAB

GMAB balance sheet

WSG - Wanda Sports Group

AMZN - Amazon

WMT - Walmart

COST - Costco Wholesale

JD - JD.com

HD - Home Depot

WBA - Walgreens Boots Alliance

BABA - Alibaba

WSG - Wanda Sports Group

AMZN - Amazon

WMT - Walmart

COST - Costco Wholesale

JD - JD.com

HD - Home Depot

WBA - Walgreens Boots Alliance

BABA - Alibaba

Frequently Asked Questions